American Journal of Kidney Diseases
Volume 55, Issue 6 , Pages 1111-1120 , June 2010

Pathogenesis of Hypertension: Interactions Among Sodium, Potassium, and Aldosterone

  • Eckhart Büssemaker, MD

      Affiliations

    • Medizinische Klinik und Poliklinik D, Universitätsklinikum Münster, Münster, Germany
    • Corresponding Author InformationAddress correspondence to Eckhart Büssemaker, MD, Medizinische Klinik und Poliklinik D, Universitätsklinikum Münster, Albert-Schweitzer-Str 33, 48149 Münster, Germany
    • ,
  • Uta Hillebrand, MD

      Affiliations

    • Medizinische Klinik und Poliklinik D, Universitätsklinikum Münster, Münster, Germany
    • ,
  • Martin Hausberg, MD

      Affiliations

    • Medizinische Klinik I, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany
    • ,
  • Hermann Pavenstädt, MD

      Affiliations

    • Medizinische Klinik und Poliklinik D, Universitätsklinikum Münster, Münster, Germany
    • ,
  • Hans Oberleithner, MD

      Affiliations

    • Institut für Physiologie II, Westfälische Wilhelms-Universität, Münster, Germany

Received 14 August 2009 ,Accepted 3 December 2009.

References 

  1. Lifton RP. Genetic determinants of human hypertension. Proc Natl Acad Sci U S A. 1995;92(19):8545–8551
  2. Mullins LJ, Bailey MA, Mullins JJ. Hypertension, kidney, and transgenics: a fresh perspective. Physiol Rev. 2006;86(2):709–746
  3. Meneton P, Jeunemaitre X, de Wardener HE, MacGregor GA. Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev. 2005;85(2):679–715
  4. Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, Sacks FM. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension. 2006;47(2):296–308
  5. Titze J, Lang R, Ilies C, et al. Osmotically inactive skin Na+ storage in rats. Am J Physiol Renal Physiol. 2003;285(6):F1108–F1117
  6. Titze J, Krause H, Hecht H, et al. Reduced osmotically inactive Na storage capacity and hypertension in the Dahl model. Am J Physiol Renal Physiol. 2002;283(1):F134–F141
  7. Schiffrin EL. Effects of aldosterone on the vasculature. Hypertension. 2006;47(3):312–318
  8. Golestaneh N, Klein C, Valamanesh F, Suarez G, Agarwal MK, Mirshahi M. Mineralocorticoid receptor-mediated signaling regulates the ion gated sodium channel in vascular endothelial cells and requires an intact cytoskeleton. Biochem Biophys Res Commun. 2001;280(5):1300–1306
  9. Oberleithner H, Ludwig T, Riethmuller C, et al. Human endothelium: target for aldosterone. Hypertension. 2004;43(5):952–956
  10. Chen W, Valamanesh F, Mirshahi T, et al. Aldosterone signaling modifies capillary formation by human bone marrow endothelial cells. Vascul Pharmacol. 2004;40(6):269–277
  11. Oberleithner H, Riethmuller C, Ludwig T, et al. Differential action of steroid hormones on human endothelium. J Cell Sci. 2006;119(pt 9):1926–1932
  12. Safar ME. Systolic hypertension in the elderly: arterial wall mechanical properties and the renin-angiotensin-aldosterone system. J Hypertens. 2005;23(4):673–681
  13. Nagata D, Takahashi M, Sawai K, et al. Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity. Hypertension. 2006;48(1):165–171
  14. Hashikabe Y, Suzuki K, Jojima T, Uchida K, Hattori Y. Aldosterone impairs vascular endothelial cell function. J Cardiovasc Pharmacol. 2006;47(4):609–613
  15. Duffy SJ, Biegelsen ES, Eberhardt RT, Kahn DF, Kingwell BA, Vita JA. Low-renin hypertension with relative aldosterone excess is associated with impaired NO-mediated vasodilation. Hypertension. 2005;46(4):707–713
  16. Hamlyn JM, Blaustein MP. Sodium chloride, extracellular fluid volume, and blood pressure regulation. Am J Physiol. 1986;251(4 pt 2):F563–F575
  17. He FJ, Markandu ND, Sagnella GA, de Wardener HE, MacGregor GA. Plasma sodium: ignored and underestimated. Hypertension. 2005;45(1):98–102
  18. de Wardener HE, He FJ, MacGregor GA. Plasma sodium and hypertension. Kidney Int. 2004;66(6):2454–2466
  19. Kaplan NM. Primary hypertension: pathogenesis. In:  Kaplan NM editors. Kaplan's Clinical Hypertension. Philadelphia, PA: Lippincott Williams & Wilkins; 2006;p. 50–121
  20. Adrogue HJ, Madias NE. Sodium and potassium in the pathogenesis of hypertension. N Engl J Med. 2007;356(19):1966–1978
  21. Kido M, Ando K, Onozato ML, et al. Protective effect of dietary potassium against vascular injury in salt-sensitive hypertension. Hypertension. 2008;51(2):225–231
  22. He FJ, MacGregor GA. Fortnightly review: beneficial effects of potassium. BMJ. 2001;323(7311):497–501
  23. Khaw KT, Barrett-Connor E. Dietary potassium and stroke-associated mortality (A 12-year prospective population study). N Engl J Med. 1987;316(5):235–240
  24. Tobian L, MacNeill D, Johnson MA, Ganguli MC, Iwai J. Potassium protection against lesions of the renal tubules, arteries, and glomeruli and nephron loss in salt-loaded hypertensive Dahl S rats. Hypertension. 1984;6(2 pt 2):I170–I176
  25. INTERSALT Cooperative Research Group. INTERSALT: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ. 1988;297(6644):319–328
  26. Dolson GM, Ellis KJ, Bernardo MV, Prakash R, Adrogue HJ. Acute decreases in serum potassium augment blood pressure. Am J Kidney Dis. 1995;26(2):321–326
  27. Adrogue HJ, Wesson DE. Role of dietary factors in the hypertension of African Americans. Semin Nephrol. 1996;16(2):94–101
  28. Krishna GG, Miller E, Kapoor S. Increased blood pressure during potassium depletion in normotensive men. N Engl J Med. 1989;320(18):1177–1182
  29. Krishna GG, Kapoor SC. Potassium depletion exacerbates essential hypertension. Ann Intern Med. 1991;115(2):77–83
  30. Grim CE, Luft FC, Miller JZ, et al. Racial differences in blood pressure in Evans County, Georgia: relationship to sodium and potassium intake and plasma renin activity. J Chronic Dis. 1980;33(2):87–94
  31. He FJ, Marciniak M, Visagie E, et al. Effect of modest salt reduction on blood pressure, urinary albumin, and pulse wave velocity in white, black, and Asian mild hypertensives. Hypertension. 2009;54(3):482–488
  32. Pimenta E, Gaddam KK, Oparil S, et al. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension. 2009;54(3):475–481
  33. Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323(1):22–27
  34. Fujiwara N, Osanai T, Kamada T, Katoh T, Takahashi K, Okumura K. Study on the relationship between plasma nitrite and nitrate level and salt sensitivity in human hypertension: modulation of nitric oxide synthesis by salt intake. Circulation. 2000;101(8):856–861
  35. Haddy FJ, Vanhoutte PM, Feletou M. Role of potassium in regulating blood flow and blood pressure. Am J Physiol Regul Integr Comp Physiol. 2006;290(3):R546–R552
  36. Amberg GC, Bonev AD, Rossow CF, Nelson MT, Santana LF. Modulation of the molecular composition of large conductance, Ca(2+) activated K(+) channels in vascular smooth muscle during hypertension. J Clin Invest. 2003;112(5):717–724
  37. Blacher J, Amah G, Girerd X, et al. Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension. Am J Hypertens. 1997;10(12 pt 1):1326–1334
  38. Brown NJ. Aldosterone and end-organ damage. Curr Opin Nephrol Hypertens. 2005;14(3):235–241
  39. Lacolley P, Labat C, Pujol A, Delcayre C, Benetos A, Safar M. Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats: effects of eplerenone. Circulation. 2002;106(22):2848–2853
  40. Quaschning T, Ruschitzka F, Shaw S, Luscher TF. Aldosterone receptor antagonism normalizes vascular function in liquorice-induced hypertension. Hypertension. 2001;37(2 pt 2):801–805
  41. Leopold JA, Dam A, Maron BA, et al. Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity. Nat Med. 2007;13(2):189–197
  42. Struthers AD, MacDonald TM. Review of aldosterone- and angiotensin II-induced target organ damage and prevention. Cardiovasc Res. 2004;61(4):663–670
  43. Abiose AK, Mansoor GA, Barry M, Soucier R, Nair CK, Hager D. Effect of spironolactone on endothelial function in patients with congestive heart failure on conventional medical therapy. Am J Cardiol. 2004;93(12):1564–1566
  44. Pu Q, Neves MF, Virdis A, Touyz RM, Schiffrin EL. Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling. Hypertension. 2003;42(1):49–55
  45. Wong S, Brennan FE, Young MJ, Fuller PJ, Cole TJ. A direct effect of aldosterone on endothelin-1 gene expression in vivo. Endocrinology. 2007;148(4):1511–1517
  46. Suzuki G, Morita H, Mishima T, et al. Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure. Circulation. 2002;106(23):2967–2972
  47. Pesen D, Hoh JH. Micromechanical architecture of the endothelial cell cortex. Biophys J. 2005;88(1):670–679
  48. Pesen D, Hoh JH. Modes of remodeling in the cortical cytoskeleton of vascular endothelial cells. FEBS Lett. 2005;579(2):473–476
  49. Davies PF, Zilberberg J, Helmke BP. Spatial microstimuli in endothelial mechanosignaling. Circ Res. 2003;92(4):359–370
  50. Kidoaki S, Matsuda T. Shape-engineered vascular endothelial cells: nitric oxide production, cell elasticity, and actin cytoskeletal features. J Biomed Mater Res A. 2007;81(3):728–735
  51. Hutcheson IR, Griffith TM. Mechanotransduction through the endothelial cytoskeleton: mediation of flow- but not agonist-induced EDRF release. Br J Pharmacol. 1996;118(3):720–726
  52. Ladage D, Brixius K, Hoyer H, et al. Mechanisms underlying nebivolol-induced endothelial nitric oxide synthase activation in human umbilical vein endothelial cells. Clin Exp Pharmacol Physiol. 2006;33(8):720–724
  53. Peng X, Haldar S, Deshpande S, Irani K, Kass DA. Wall stiffness suppresses Akt/eNOS and cytoprotection in pulse-perfused endothelium. Hypertension. 2003;41(2):378–381
  54. Edwards G, Dora KA, Gardener MJ, Garland CJ, Weston AH. K+ is an endothelium-derived hyperpolarizing factor in rat arteries. Nature. 1998;396(6708):269–272
  55. Dawes M, Sieniawska C, Delves T, Dwivedi R, Chowienczyk PJ, Ritter JM. Barium reduces resting blood flow and inhibits potassium-induced vasodilation in the human forearm. Circulation. 2002;105(11):1323–1328
  56. Dwivedi R, Saha S, Chowienczyk PJ, Ritter JM. Block of inward rectifying K+ channels (KIR) inhibits bradykinin-induced vasodilatation in human forearm resistance vasculature. Arterioscler Thromb Vasc Biol. 2005;25(2):e7–e9
  57. Bussemaker E, Popp R, Binder J, Busse R, Fleming I. Characterization of the endothelium-derived hyperpolarizing factor (EDHF) response in the human interlobar artery. Kidney Int. 2003;63(5):1749–1755
  58. Bussemaker E, Wallner C, Fisslthaler B, Fleming I. The Na-K-ATPase is a target for an EDHF displaying characteristics similar to potassium ions in the porcine renal interlobar artery. Br J Pharmacol. 2002;137(5):647–654
  59. Oberleithner H, Riethmuller C, Schillers H, MacGregor GA, de Wardener HE, Hausberg M. Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc Natl Acad Sci U S A. 2007;104(41):16281–16286
  60. Li J, White J, Guo L, et al. Salt inactivates endothelial nitric oxide synthase in endothelial cells. J Nutr. 2009;139(3):447–451
  61. Oberleithner H, Callies C, Kusche-Vihrog K, et al. Potassium softens vascular endothelium and increases nitric oxide release. Proc Natl Acad Sci U S A. 2009;106(8):2829–2834
  62. Safar ME, Boudier HS. Vascular development, pulse pressure, and the mechanisms of hypertension. Hypertension. 2005;46(1):205–209
  63. Buyck JF, Blacher J, Kesse-Guyot E, et al. Differential associations of dietary sodium and potassium intake with blood pressure: a focus on pulse pressure. J Hypertens. 2009;27(6):1158–1164
  64. Machnik A, Neuhofer W, Jantsch J, et al. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med. 2009;15(5):545–552
  65. Heer M, Baisch F, Kropp J, Gerzer R, Drummer C. High dietary sodium chloride consumption may not induce body fluid retention in humans. Am J Physiol Renal Physiol. 2000;278(4):F585–F595
  66. Titze J, Maillet A, Lang R, et al. Long-term sodium balance in humans in a terrestrial space station simulation study. Am J Kidney Dis. 2002;40(3):508–516
  67. Titze J, Bauer K, Schafflhuber M, et al. Internal sodium balance in DOCA-salt rats: a body composition study. Am J Physiol Renal Physiol. 2005;289(4):F793–F802
  68. Ziomber A, Machnik A, Dahlmann A, et al. Sodium-, potassium-, chloride-, and bicarbonate-related effects on blood pressure and electrolyte homeostasis in deoxycorticosterone acetate-treated rats. Am J Physiol Renal Physiol. 2008;295(6):F1752–F1763
  69. Leonard AM, Chafe LL, Montani JP, Van Vliet BN. Increased salt-sensitivity in endothelial nitric oxide synthase-knockout mice. Am J Hypertens. 2006;19(12):1264–1269
  70. Manchester RC. The diurnal rhythm in water and mineral exchange. J Clin Invest. 1933;12(6):995–1008
  71. Wesson LG, Lauler DP. Diurnal cycle of glomerular filtration rate and sodium and chloride excretion during responses to altered salt and water balance in man. J Clin Invest. 1961;40:1967–1977
  72. Stanbury SW, Thomson AE. Diurnal variation in electrolyte excretion. Clin Sci (Lond). 1951;10(3):267–293
  73. Dyer AR, Martin GJ, Burton WN, Levin M, Stamler J. Blood pressure and diurnal variation in sodium, potassium, and water excretion. J Hum Hypertens. 1998;12(6):363–371
  74. Goldman R. Studies in diurnal variation of water and electrolyte excretion; nocturnal diuresis of water and sodium in congestive cardiac failure and cirrhosis of the liver. J Clin Invest. 1951;30(11):1191–1199
  75. Gumz ML, Stow LR, Lynch IJ, et al. The circadian clock protein Period 1 regulates expression of the renal epithelial sodium channel in mice. J Clin Invest. 2009;119(8):2423–2434

 Originally published online as doi:10.1053/j.ajkd.2009.12.022 on March 11, 2010.

PII: S0272-6386(09)01660-6

doi: 10.1053/j.ajkd.2009.12.022

American Journal of Kidney Diseases
Volume 55, Issue 6 , Pages 1111-1120 , June 2010

Article Tools

* Image Usage & Resolution